Navigation Links
New clinical trial to determine ovarian cancer risks in African-American women

University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting an important new study addressing the lack of knowledge about causes and risk factors for ovarian cancer in African American women. The five-year study is funded by the National Cancer Institute through Case Western Reserve University School of Medicine.

Ovarian cancer, though relatively rare, is the most lethal of all gynecologic cancers. It is the fifth most common cause of cancer death among women behind lung, breast, colorectal and pancreas. African American women have lower incidence rates than women of other races yet have a poorer survival rate.

"This study hopes to address the lack of knowledge about causes of ovarian cancer among African-American women by establishing a multi-site, national collaboration that will educate, treat, and assess both environmental and genetic risk factors in African American women," said Jill S. Barnholtz-Sloan, PhD, the study's principal investigator at UH Case Medical Center and Assistant Professor, Case Western Reserve University School of Medicine. "Ovarian cancer is a deadly disease and it is important that we better understand what causes this disease if we have any hope of preventing it in the future."

The nine-state collaborative study aims to enroll 1,000 African American women between the ages of 20-79 with primary ovarian cancer and an equal amount of same-aged, healthy African American women. Researchers hope to discover how risk factors for ovarian caner in African American women are similar or different from the established risk factors in white women and if the differences can account for racial differences in ovarian cancer incidence (i.e. proportion of newly diagnosed ovarian cancer cases).

"This study will not only help us determine differences in risk factors between African American women and white women but we also anticipate that this study will provide a foundation to conduct studies of other cancers in African American women in the future." said Steven Waggoner, MD, co-primary investigator on the study, Chief of Gynecologic Oncology at UH Case Medical Center and Associate Professor at Case Western Reserve University School of Medicine. "Furthermore it is important for us to determine what factors are associated with poorer survival rates in African American women."


Contact: Alicia Reale
University Hospitals Case Medical Center

Related medicine news :

1. Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
2. Most Guidelines for Infectious Diseases Dont Come From Clinical Trial Findings
3. Quality of life measures in breast cancer clinical trials
4. Quality of Life Key Measure in Breast Cancer Clinical Trials
5. Clinical waste management needs specialized regulation
6. VCU findings may help explain some major clinical symptoms of preeclampsia
7. Clinical practitioners not adhering to evidence-based guidelines for osteoarthritis
8. Clinical decision support systems help control inappropriate medical imaging, study suggests
9. Peptide delivers 1-2 punch to breast cancer in pre-clinical study
10. Collaboration offers NIH Clinical Center resources to Damon Runyon clinical investigators
11. Use the right metaphor to get patients to enroll in clinical trials
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: